Kura Oncology and Kyowa Kirin Forge Global Partnership to Develop and Commercialize Ziftomenib for Acute Myeloid Leukemia

Metropolis Healthcare's Landmark Study Highlights the Role of Molecular Profiling in Advancing Lung Cancer Care

Novartis Acquires Kate Therapeutics for $1.1 Billion to Advance Gene Therapies for Neuromuscular Diseases

OneCell Diagnostics Secures $16M to Revolutionize Cancer Diagnostics

FDA Grants Accelerated Approval to Ziihera® (zanidatamab-hrii) for HER2-Positive Biliary Tract Cancer

Illumina Unveils TruSight™ Oncology 500 v2 for Comprehensive Genomic Profiling

Tagomics Partners with Agilent Technologies to Revolutionize Multiomic Biomarker Discovery

Bio-Techne Partners with Leader Life Sciences to Expand in the GCC Region

Owkin and Proscia Partner to Revolutionize MSI Testing for Colorectal Cancer with AI-Powered Solutions

Telix Expands Theranostic Pipeline with FAP-Targeting Radiopharmaceuticals

Alamar Biosciences and The Michael J. Fox Foundation Partner to Advance Parkinson’s Disease Biomarker Discovery

Stilla Technologies Partners with Source BioScience to Advance Genomics in the UK and Ireland

Quell Therapeutics and AstraZeneca Advance CAR-Treg Therapy for Type 1 Diabetes

AbbVie’s ELAHERE® Approved in the EU for Platinum-Resistant Ovarian Cancer

AstraZeneca’s Tagrisso Recommended for Approval in EU for Unresectable EGFR-Mutated NSCLC